£50m NHS cancer drug fund branded 'unfair'

A £50 million NHS fund for cancer drugs deemed too expensive by NICE may be unfair and could run out of cash, a GP prescribing expert has warned.

NICE: over-ruled by DoH fudn (Photograph: Jason Heath Lancy)
NICE: over-ruled by DoH fudn (Photograph: Jason Heath Lancy)

The fund was launched last week under DoH plans to improve use of new treatments.

But Dr Bill Beeby, GPC prescribing subcommittee chairman, questioned whether it was right to over-rule NICE's decisions on cost effectiveness.

'Is it fair to have an organisation called NICE, which is meant to make that assessment, and then find pressure on the government leads to a special fund for some people?' he said.

The launch came as a report by England's cancer director Professor Sir Mike Richards showed UK use of new cancer drugs lags behind most of Europe.

Sir Mike said the Cancer Drug Fund, launching in April 2011 but starting in interim form from October in England, would help 'several thousand' patients.

But Dr Beeby said it only 'scratched the surface'. 'Cancer drugs can cost £50,000 or more. When you start dividing £50 million by those sorts of figures, it doesn't go far.'

The Alzheimer's Society said Sir Mike's report was a 'scathing indictment of problems with access to dementia drugs' after it ranked the UK 11th out of 14 countries.

Asked why there was no new fund for other disease areas, the DoH said: 'There are some innovative new cancer treatments NICE cannot approve due to cost-effectiveness.

In the long term, the government plans to introduce value-based pricing and make new medicines available to NHS patients.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP training: How an audit e-portfolio log entry is assessed

GP training: How an audit e-portfolio log entry is assessed

The second of two articles on audit during GP training looks at how the quality improvement...

GP training: Writing up an audit for your e-portfolio

GP training: Writing up an audit for your e-portfolio

In the first of two articles on how to write up an audit, a typical e-portfolio entry...

UK ups order of 95% effective COVID-19 vaccine by 2m doses

UK ups order of 95% effective COVID-19 vaccine by 2m doses

The UK has increased its order of the 95% effective Moderna COVID-19 vaccine to 7m...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Which COVID-19 vaccines are lined up for roll-out on the NHS?

Which COVID-19 vaccines are lined up for roll-out on the NHS?

As GPs and their teams prepare for delivering a COVID-19 vaccination programme that...

Shielded patients and care home residents to receive free vitamin D

Shielded patients and care home residents to receive free vitamin D

Patients on the shielding list and care homes are to be provided with free vitamin...